loadpatents
name:-0.015042066574097
name:-0.0028331279754639
name:-0.00042104721069336
Waring; Jeffrey F. Patent Filings

Waring; Jeffrey F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Waring; Jeffrey F..The latest application filed is for "methods for treating hcv".

Company Profile
0.2.11
  • Waring; Jeffrey F. - Franklin WI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Treating Hcv
App 20160333404 - Bernstein; Barry M. ;   et al.
2016-11-17
Methods For Treating Hcv
App 20160237491 - Cohen; Daniel E. ;   et al.
2016-08-18
Methods For Treating Hcv
App 20160228496 - Cohen; Daniel E. ;   et al.
2016-08-11
Neuronal Nicotinic Agonists And Methods Of Correlating Comt Snps
App 20130317056 - Haig; George M. ;   et al.
2013-11-28
Biomarkers And Methods For Detecting Alzheimer's Disease
App 20120178637 - Devanarayan; Viswanath ;   et al.
2012-07-12
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
App 20100261731 - Kempf; Dale J. ;   et al.
2010-10-14
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
Grant 7,547,678 - Kempf , et al. June 16, 2
2009-06-16
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an ugtiai substrate
App 20080138315 - Kempf; Dale J. ;   et al.
2008-06-12
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
Grant 7,320,961 - Kempf , et al. January 22, 2
2008-01-22
Methods for characterizing tissue or organ condition or status
App 20050143628 - Dai, Xudong ;   et al.
2005-06-30
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
App 20040242509 - Kempf, Dale J. ;   et al.
2004-12-02
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
App 20040192624 - Kempf, Dale J. ;   et al.
2004-09-30
Methods for identifying compounds that inhibit or reduce PTP1B expression
App 20030108883 - Rondinone, Cristina M. ;   et al.
2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed